PT Brigit Biofarmaka Technologi Tbk (OBAT) Fair Value & Analysis
Consumer Defensive · ID · Market cap 121B IDR
Fair value as of: Jun 25, 2026
Analysis
PT Brigit Biofarmaka Technologi Tbk (OBAT) currently trades at 246.00 IDR, while our model-based Fair Value estimate is 729.02 IDR — implying the stock looks roughly 196.3% undervalued today. We read business quality at 81/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. In addition, it provides lip gloss, cushion, foundation, eyeliner, and blush on balm. The company was founded in 2015 and is based in Sukoharjo, Indonesia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is PT Brigit Biofarmaka Technologi Tbk (OBAT) undervalued?
What is the fair value of OBAT?
What is the quality score of OBAT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.